These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7421555)

  • 1. [Comparative bacteriologic in vitro studies with pipemidic acid and nalidixic acid].
    Grimm H
    Med Welt; 1980 Aug; 31(33):1189-91. PubMed ID: 7421555
    [No Abstract]   [Full Text] [Related]  

  • 2. [A comparison of the effects of three urinary infection chemotherapeutics - nalidixic, oxolinic, and pipemidic acids (author's transl)].
    Langsádl L; Polívková-Konícková L; Roubínek F
    Cas Lek Cesk; 1979 May; 118(19):588-92. PubMed ID: 498218
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antibacterial in-vitro activity of pipemidic acid and nalidixic acid (author's transl)].
    Peters G; Freiesleben H; Marre R; Metz H; Tannenberg H; Pulverer G
    Dtsch Med Wochenschr; 1979 Jun; 104(26):946-8. PubMed ID: 110574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibacterial activity of pipemidic acid].
    Torosantucci A; Cialdea L; Calabrò AM; Fillini G
    Ann Ist Super Sanita; 1982; 18(3):467-70. PubMed ID: 7187832
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative activities of AM-715 and pipemidic and nalidixic acids against experimentally induced systemic and urinary tract infections.
    Hirai K; Ito A; Abe Y; Suzue S; Irikura T; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1981 Jan; 19(1):188-9. PubMed ID: 6454381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.
    Muytjens HL; van der Ros-van de Repe J; van Veldhuizen G
    Antimicrob Agents Chemother; 1983 Aug; 24(2):302-4. PubMed ID: 6227281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance and importance of the use of pipemidic acid in the therapy of acute and chronic urinary tract infections].
    Di Silverio F; Criniti P; Romano G; Zezza A; Galfano G
    Clin Ter; 1980 May; 93(3):275-85. PubMed ID: 7449341
    [No Abstract]   [Full Text] [Related]  

  • 8. Cross resistance of quinolone derivatives in gram-negative bacteria.
    Barba D; Pennucci C; Esposito S; Galante D
    Chemioterapia; 1985 Apr; 4(2):192-6. PubMed ID: 3159488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of norfloxacin in synthetic media and human urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
    Shah PM; Ottnad-Walz M; Stille W
    Methods Find Exp Clin Pharmacol; 1983 Dec; 5(10):731-4. PubMed ID: 6231438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of pipemidic acid in the treatment of urinary tract infections].
    Pagani G
    Clin Ter; 1979 Dec; 91(6):617-36. PubMed ID: 544164
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical trial of drugs for treating urological infections--pipemidic acid].
    Belovezhdov N; Talakova Ch; Angelova I; Chakŭrski I; Koĭchev A
    Vutr Boles; 1985; 24(2):61-5. PubMed ID: 3898589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nalidixic acid, pipemidic acid and cinoxacin on chondrocyte metabolism in explants of articular cartilage.
    Brand HS; van Kampen GP; van der Korst JK
    Clin Exp Rheumatol; 1990; 8(4):393-5. PubMed ID: 2397627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pipemidic acid in the treatment of various infective disorders of the urinary tract in a series of obstetric and gynecologic patients].
    Schilirò S; D'Asta S
    Minerva Ginecol; 1979 Sep; 31(9):669-78. PubMed ID: 537710
    [No Abstract]   [Full Text] [Related]  

  • 14. Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids.
    Inoue S; Ohue T; Yamagishi J; Nakamura S; Shimizu M
    Antimicrob Agents Chemother; 1978 Aug; 14(2):240-5. PubMed ID: 358918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pipemidic acid: a new antibiotic for the urinary tract. A comparative, double-blind study of pipemidic acid and amoxidillin].
    Oosterlinck W; Welvaert P; Verbaeys A; Schelfout W; Wijndaele JJ; de Maeyer P
    Acta Urol Belg; 1980 Oct; 48(4):471-7. PubMed ID: 7006346
    [No Abstract]   [Full Text] [Related]  

  • 16. [Deblaston].
    Hofstetter A
    Urologe A; 1979 Jul; 18(4):207-8. PubMed ID: 473455
    [No Abstract]   [Full Text] [Related]  

  • 17. Criteria for the interpretation of the pipemidic acid agar diffusion test by the Kirby-Bauer method.
    Grimm H
    Arzneimittelforschung; 1983; 33(7):913-5. PubMed ID: 6414487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical contribution to the study of pipemidic acid in urinary tract infections in a urology clinic].
    Pagani G
    Clin Ter; 1980 Jul; 94(2):165-71. PubMed ID: 7004759
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pipemidic acid--an alternative in the oral treatment of urinary tract infections and prostatitis].
    Bischoff W
    Fortschr Med; 1982 Dec; 100(47-48):2234-6. PubMed ID: 7160818
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical studies on pipemidic acid.
    Ueda Y; Matsumoto F; Saito A; Ohkoshi M; Kawamura N; Nishiura T; Kawada Y; Ban Y
    Jpn J Antibiot; 1978 Sep; 31(9):528-35. PubMed ID: 101691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.